Antimicrobial Peptide-Loaded Hyaluronic Acid Hydrogel for Treating Chronic Wounds

An injectable hyaluronic acid hydrogel loaded with antimicrobial peptide PP4-3.1 promotes cell growth while fighting infection in chronic wounds.

Petit, Noémie et al.·Biomaterials science·2025·very-lowin-vitro
RPEP-13034In Vitrovery-low2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
very-low
Sample
N=Not applicable (in vitro)
Participants
Not applicable (biomaterials)

What This Study Found

AcHyA hydrogels functionalized with gelatin and antimicrobial peptide PP4-3.1 formed stable in situ gels that enhanced cellular responses while providing antimicrobial activity for chronic wounds.

Key Numbers

0.5% gelatin identified as optimal. Rapid gelation, elastic behavior, uniform mesh size. Supported fibroblast and endothelial cell adhesion and spreading. AMP PP4-3.1 provided antimicrobial activity.

How They Did This

Biomaterials study developing and characterizing AcHyA-gelatin and AcHyA-AMP hydrogels via thiol-acrylate crosslinking, assessing mechanical properties, cell compatibility, and antimicrobial activity.

Why This Research Matters

Chronic wound infections are a major healthcare burden. A single material that both promotes healing and prevents infection could simplify wound care and improve outcomes.

The Bigger Picture

Combining bioactive hydrogels with antimicrobial peptides represents a growing trend in wound care materials that deliver multiple therapeutic functions simultaneously.

What This Study Doesn't Tell Us

In vitro characterization study. Wound healing efficacy in animal models or clinical settings has not been tested.

Questions This Raises

  • ?How long does the antimicrobial peptide remain active within the hydrogel?
  • ?Would this hydrogel be effective against biofilm-forming bacteria common in chronic wounds?

Trust & Context

Key Stat:
Dual function: heal + protect Single hydrogel material promotes cell growth while delivering antimicrobial peptide to fight wound infection
Evidence Grade:
Biomaterials development study with in vitro testing. Clinical wound healing efficacy remains to be demonstrated.
Study Age:
Published in 2025, contributing to the active field of bioactive wound care materials.
Original Title:
Development of a bioactive hyaluronic acid hydrogel functionalised with antimicrobial peptides for the treatment of chronic wounds.
Published In:
Biomaterials science, 13(13), 3561-3575 (2025)
Database ID:
RPEP-13034

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What makes this wound dressing different?

It combines hyaluronic acid (which supports natural wound healing) with an antimicrobial peptide (which fights infection) in a single injectable gel. This dual-function approach could simplify chronic wound treatment.

What is PP4-3.1?

PP4-3.1 is a synthetic antimicrobial peptide that kills bacteria by disrupting their cell membranes. When loaded into a hydrogel, it provides sustained antimicrobial protection at the wound site.

Read More on RethinkPeptides

Cite This Study

RPEP-13034·https://rethinkpeptides.com/research/RPEP-13034

APA

Petit, Noémie; Gomes, Ana; Chang, Yu-Yin Joanne; Da Silva, Jessica; Leal, Ermelindo C; Carvalho, Eugénia; Gomes, Paula; Browne, Shane. (2025). Development of a bioactive hyaluronic acid hydrogel functionalised with antimicrobial peptides for the treatment of chronic wounds.. Biomaterials science, 13(13), 3561-3575. https://doi.org/10.1039/d5bm00567a

MLA

Petit, Noémie, et al. "Development of a bioactive hyaluronic acid hydrogel functionalised with antimicrobial peptides for the treatment of chronic wounds.." Biomaterials science, 2025. https://doi.org/10.1039/d5bm00567a

RethinkPeptides

RethinkPeptides Research Database. "Development of a bioactive hyaluronic acid hydrogel function..." RPEP-13034. Retrieved from https://rethinkpeptides.com/research/petit-2025-development-of-a-bioactive

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.